164 related articles for article (PubMed ID: 15132233)
1. Fatal methotrexate-induced pneumonitis in a psoriatic patient.
Mazokopakis E; Katsogridakis K; Koutsopoulos A; Voloudaki A; Froudarakis M; Kritikos H; Vrentzos G
Mil Med; 2004 Apr; 169(4):298-300. PubMed ID: 15132233
[TBL] [Abstract][Full Text] [Related]
2. Pneumonitis complicating methotrexate therapy for pustular psoriasis.
Ameen M; Taylor DA; Williams IP; Wells AU; Barkert JN
J Eur Acad Dermatol Venereol; 2001 May; 15(3):247-9. PubMed ID: 11683290
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients.
Imokawa S; Colby TV; Leslie KO; Helmers RA
Eur Respir J; 2000 Feb; 15(2):373-81. PubMed ID: 10706507
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: report of five cases and review of the literature.
Salaffi F; Manganelli P; Carotti M; Subiaco S; Lamanna G; Cervini C
Clin Rheumatol; 1997 May; 16(3):296-304. PubMed ID: 9184269
[TBL] [Abstract][Full Text] [Related]
5. [Dyspnea during administration of methotrexate: not anything to treat casually].
van der Veen MJ; Teding van Berkhout F; Bijlsma JW
Ned Tijdschr Geneeskd; 1991 Mar; 135(12):522-5. PubMed ID: 2027397
[TBL] [Abstract][Full Text] [Related]
6. Rheumatoid arthritis associated with methotrexate-induced pneumonitis: improvement with i.v. cyclophosphamide therapy.
Suwa A; Hirakata M; Satoh S; Mimori T; Utsumi K; Inada S
Clin Exp Rheumatol; 1999; 17(3):355-8. PubMed ID: 10410272
[TBL] [Abstract][Full Text] [Related]
7. [Correct use of methotrexate].
Verduijn MM; van den Bemt BJ; Dijkmans BA; van der Waal RI; Horikx A
Ned Tijdschr Geneeskd; 2009; 153():A696. PubMed ID: 19785852
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate-induced pulmonary toxicity in psoriatic arthritis (PsA): case presentation and literature review.
Rondon F; Mendez O; Spinel N; Ochoa C; Saavedra C; Penaranda E; Garcia-Valladares I; Espinoza LR; Iglesias-Gamarra A
Clin Rheumatol; 2011 Oct; 30(10):1379-84. PubMed ID: 21614476
[TBL] [Abstract][Full Text] [Related]
9. [Severe pneumonitis as a complication of low-dose methotrexate therapy in psoriasis-associated polyarthritis].
Schnabel A; Gross WL
Dtsch Med Wochenschr; 1995 Sep; 120(36):1223-5. PubMed ID: 7671777
[No Abstract] [Full Text] [Related]
10. Methotrexate in psoriatic arthritis.
Cutolo M; Seriolo B; Pizzorni C; Craviotto C; Sulli A
Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S76-80. PubMed ID: 12463453
[TBL] [Abstract][Full Text] [Related]
11. Folic acid and cyanocobalamin levels in serum and erythrocytes during low-dose methotrexate therapy of rheumatoid arthritis and psoriatic arthritis patients.
Leeb BF; Witzmann G; Ogris E; Studnicka-Benke A; Andel I; Schweitzer H; Smolen JS
Clin Exp Rheumatol; 1995; 13(4):459-63. PubMed ID: 7586777
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of CD4 to CD8 T-cell ratios in lymphocytic alveolitis associated with methotrexate-induced pneumonitis.
Fuhrman C; Parrot A; Wislez M; Prigent H; Boussaud V; Bernaudin JF; Mayaud C; Cadranel J
Am J Respir Crit Care Med; 2001 Oct; 164(7):1186-91. PubMed ID: 11673207
[TBL] [Abstract][Full Text] [Related]
13. Severe reversible interstitial pneumonitis induced by low dose methotrexate: report of a case and review of the literature.
Green L; Schattner A; Berkenstadt H
J Rheumatol; 1988 Jan; 15(1):110-2. PubMed ID: 3280790
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of patients with rheumatoid arthritis and methotrexate induced pneumonitis.
Ohosone Y; Okano Y; Kameda H; Fujii T; Hama N; Hirakata M; Mimori T; Akizuki M; Ikeda Y
J Rheumatol; 1997 Dec; 24(12):2299-303. PubMed ID: 9415631
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate pneumonitis induced by intrathecal methotrexate therapy: a case report with pharmacokinetic data.
Gutin PH; Green MR; Bleyer WA; Bauer VL; Wiernik PH; Walker MD
Cancer; 1976 Oct; 38(4):1529-34. PubMed ID: 1036466
[TBL] [Abstract][Full Text] [Related]
16. Fatal low-dose methotrexate toxicity: A case report and literature review.
Ouellette S; Shah R; Razi S; Ashforth G; Wassef C
Dermatol Ther; 2022 Dec; 35(12):e15945. PubMed ID: 36259229
[TBL] [Abstract][Full Text] [Related]
17. Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review.
Whittle SL; Hughes RA
Rheumatology (Oxford); 2004 Mar; 43(3):267-71. PubMed ID: 14963199
[TBL] [Abstract][Full Text] [Related]
18. Bacillary angiomatosis following the use of long-term methotrexate therapy: a case report.
Kreitzer T; Saoud A
W V Med J; 2006; 102(1):317-8. PubMed ID: 16706324
[TBL] [Abstract][Full Text] [Related]
19. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
Ortiz Z; Shea B; Suarez Almazor M; Moher D; Wells G; Tugwell P
Cochrane Database Syst Rev; 2000; (2):CD000951. PubMed ID: 10796393
[TBL] [Abstract][Full Text] [Related]
20. Systemic therapy of psoriasis: methotrexate.
Kozub P; Simaljakova M
Bratisl Lek Listy; 2011; 112(7):390-4. PubMed ID: 21744734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
